Endotoxin-induced macrophage gene expression depends on platelet- activating factor

Archives of Surgery

Volumn 132, Issue 12, 1997, Pages 1342-1347

  Lo, Chong Jeh ^a,b   Cryer, H Gill ^a   Fu, Minjuan ^a   Kim, Barbara ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ARACHIDONIC ACID; CALCIUM ANTAGONIST; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MANOALIDE; MESSENGER RNA; PHOSPHOLIPASE A2 INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR; VERAPAMIL; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; GENE EXPRESSION; MACROPHAGE ACTIVATION; MULTIPLE ORGAN FAILURE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RABBIT; SEPSIS;

EID: 0031467863     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1997.01430360088016     Document Type: Article

References (37)

1. Parrillo JE. Management of septic shock: present and future. Ann Intern Med. 1991;115:491-492.
2. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. JAMA. 1994; 271:226-233.
3. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA. 1992;268:3452-3455.
4. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
5. Johnston RB. Monocytes and macrophages. N Engl J Med. 1988;318:747-752.
6. Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol. 1993;53:267-289.
7. Michie HR, Spriggs DR, Manogue KR, et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988;104: 280-286.
8. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
9. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987;39:97-145.
10. Moore JM, Earnest MA, DiSimone AG, Abumrad NN, Fletcher JR. A PAF receptor antagonist, BN52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia. Cir Shock. 1991;35:53-59.
11. Fletcher JR, Disimone G, Earnest MA. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. Ann Surg. 1990;211:312-316.
12. Filep J, Herman F, Braquet P, Mozes T. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Comm. 1989;158:353-359.
13. Carter MB, Wilson MA, Wead WB, Garrison RN. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion. J Surg Res. 1996;60:403-408.
14. Toth PD, Mikulaschek AW. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat. Cir Shock. 1986;20:193-203.
15. Brain JE, Frank R. Alveolar macrophage adhesion: wash electrolyte composition and free cell yield. J Appl Physiol. 1973;34:75-80.
16. Maier RV, Hahnel GB. Platelet-activating factor augments tumor necrosis factor and procoagulant activity. J Surg Res. 1992;52:258-264.
17. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984;68:167-175.
18. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Ann Rev Immunol. 1989;7:625-655.
19. 2 in human volunteers challenged with intravenous endotoxin. Inflammation. 1992;16: 561-570.
20. 2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Can J Physiol Pharmacol. 1983;61:561-566.
21. 2 levels with circulatory collapse. Crit Care Med. 1988;16:1-7.
22. 2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci. 1992;50:807-811.
23. 2 production in vivo of the macrophage-like P388D1 cell. J Biol Chem. 1989;264:8520-8528.
24. Mayer AMS, Glaser KB, Jacobs RS. Regulation of eicosanoid biosynthesis in vitro and in vivo by the marine natural product manoalide: a potent inactivator of venom phospholipases. J Pharmacol Exp Ther. 1988;244:871-878.
25. 2. Biochem Biophys Res Commun. 1986;137:404-410.
26. Terashita Z-I, Tsushima S, Yoshioka Y, Nomura H, Inada Y, Nishikawa K. CV-3988: a specific antagonist of platelet activating factor (PAF). Life Sci. 1983;32: 1975-1982.
27. Terashita Z-I, Imura Y, Nishikawa K, Sumida S. Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol. 1985;109:257-261.
28. Chang S-W, Feddersen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest. 1987;79:1498-1509.
29. 2+-dependent protein kinase. Science. 1984; 224:622-625.
30. Gardner CR, Laskin JD, Laskin DL. Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells. J Leukoc Biol. 1993;53:190-196.
31. Lo C, Garcia I, Cryer H, Maier RV. Calcium and calmodulin regulate LPS-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. Arch Surg. 1996;131:44-50.
32. Kucey DS, Cheung PYC, Rotstein OD. Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism. Infect Immun. 1992;60:944-950.
33. Sugiura T, Nakajima M, Sekiguchi N, Nakagawa Y, Waku K. Different fatty chain compositions of alkenylacyl, alkylacyl and diacyl phospholipids in rabbit alveolar macrophages: high amounts of arachidonic acid in ether phospholipids. Lipids. 1983;18:125-129.
34. Mueller HW, O'Flaherty JT, Greene DG, Samuel MP, Wykle RL. 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. J Lipid Res. 1984;25:383-388.
35. Mueller HW, Purdon AD, Smith JB, Wykle RL. 1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. Lipids. 1983;18:814-819.
36. Sumida C, Graber R, Nunez E. Role of fatty acids in signal transduction: modulators and messengers. Prostaglandins Leukot Essent Fatty Acids. 1993;48:117-122.
37. Dennis EA, Rhee SG, Biliah MM, Hannun YA. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 1991;5:2068-2077.